Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models

Medicine & Life Sciences

• KB R7785 100%
• Matrix Metalloproteinase Inhibitors 56%
• Colon 37%
• Adenocarcinoma 36%
• Neoplasm Metastasis 29%
• Neoplasms 15%
• Endothelial Cells 6%
• Lung 6%
• Growth 4%
• Matrix Metalloproteinase 3 3%
• Matrix Metalloproteinase 1 3%
• Blood Vessels 3%
• DNA Nucleotidylexotransferase 3%
• von Willebrand Factor 3%
• Matrix Metalloproteinase 9 3%
• Tail 2%
• Matrix Metalloproteinases 2%
• Tumor Burden 2%
• Veins 2%
• Staining and Labeling 1%
• Apoptosis 1%
• Antibodies 1%
• In Vitro Techniques 1%